List of Tables
    Table 1. Respiratory Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Respiratory Drugs Market Trends
    Table 3. Respiratory Drugs Market Drivers
    Table 4. Respiratory Drugs Market Challenges
    Table 5. Respiratory Drugs Market Restraints
    Table 6. Global Respiratory Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Respiratory Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Respiratory Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Respiratory Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Respiratory Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Respiratory Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Respiratory Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Respiratory Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Respiratory Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Respiratory Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Respiratory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Respiratory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2021)
    Table 18. Top Players of Respiratory Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Respiratory Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Respiratory Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Respiratory Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Respiratory Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Respiratory Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Respiratory Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Respiratory Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Respiratory Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Respiratory Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Respiratory Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Respiratory Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Respiratory Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Respiratory Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Respiratory Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Respiratory Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Respiratory Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Respiratory Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Respiratory Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Respiratory Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Respiratory Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Respiratory Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Respiratory Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. FibroGen Corporation Information
    Table 43. FibroGen Description and Business Overview
    Table 44. FibroGen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. FibroGen Respiratory Drugs Product
    Table 46. FibroGen Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Dr. Reddy's Laboratories Corporation Information
    Table 53. Dr. Reddy's Laboratories Description and Business Overview
    Table 54. Dr. Reddy's Laboratories Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Dr. Reddy's Laboratories Product
    Table 56. Dr. Reddy's Laboratories Recent Development
    Table 57. Afferent Pharmaceuticals Corporation Information
    Table 58. Afferent Pharmaceuticals Description and Business Overview
    Table 59. Afferent Pharmaceuticals Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Afferent Pharmaceuticals Product
    Table 61. Afferent Pharmaceuticals Recent Development
    Table 62. Dainippon Sumitomo Corporation Information
    Table 63. Dainippon Sumitomo Description and Business Overview
    Table 64. Dainippon Sumitomo Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Dainippon Sumitomo Product
    Table 66. Dainippon Sumitomo Recent Development
    Table 67. Abbott Corporation Information
    Table 68. Abbott Description and Business Overview
    Table 69. Abbott Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Abbott Product
    Table 71. Abbott Recent Development
    Table 72. Horizon Pharma Corporation Information
    Table 73. Horizon Pharma Description and Business Overview
    Table 74. Horizon Pharma Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Horizon Pharma Product
    Table 76. Horizon Pharma Recent Development
    Table 77. Amgen Corporation Information
    Table 78. Amgen Description and Business Overview
    Table 79. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Amgen Product
    Table 81. Amgen Recent Development
    Table 82. Pfizer Corporation Information
    Table 83. Pfizer Description and Business Overview
    Table 84. Pfizer Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Pfizer Product
    Table 86. Pfizer Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Respiratory Drugs Customers List
    Table 90. Respiratory Drugs Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Respiratory Drugs Product Picture
    Figure 2. Global Respiratory Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Respiratory Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Respiratory Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Respiratory Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Respiratory Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Respiratory Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Respiratory Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Respiratory Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Respiratory Drugs Report Years Considered
    Figure 11. Product Picture of Asthma
    Figure 12. Product Picture of Chronic Obstructive Pulmonary Disease
    Figure 13. Product Picture of Idiopathic Pulmonary Fibrosis
    Figure 14. Product Picture of Cystic Fibrosis
    Figure 15. Global Respiratory Drugs Market Share by Type in 2022 & 2028
    Figure 16. Global Respiratory Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Respiratory Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Respiratory Drugs Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Respiratory Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Respiratory Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Respiratory Drugs Market Share by Type in 2022 & 2028
    Figure 22. United States Respiratory Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Respiratory Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Respiratory Drugs Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Respiratory Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Respiratory Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Ambulatory Care
    Figure 29. Product Picture of Others
    Figure 30. Global Respiratory Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Respiratory Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Respiratory Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Respiratory Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Respiratory Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Respiratory Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Respiratory Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Respiratory Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Respiratory Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Respiratory Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Respiratory Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Respiratory Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Respiratory Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Respiratory Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. United States Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Mexico Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Respiratory Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Respiratory Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UK Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Respiratory Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Respiratory Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Vietnam Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Respiratory Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Respiratory Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Respiratory Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Respiratory Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Respiratory Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Respiratory Drugs Value Chain
    Figure 77. Respiratory Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed